ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Venture capital in HealthTech and TechBio has undergone a 24-month cleansing, replacing hype-driven valuations with deep technical scrutiny. The era of consumer-facing digital health apps is ending. Growth capital now flows toward foundational infrastructure, not vague AI healthcare promises.
Tap to vote and see what everyone thinks.
Summary by ByteBrief